INDV

Dopo l'orario di chiusura: 30.47

Indivior Pharmaceuticals Inc (INDV)

Panoramica Notizia Cronologia dei prezzi Forum Previsione

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Indivior Pharmaceuticals Inc Stock (INDV) Company Profile

Indivior Pharmaceuticals Inc

Healthcare (1118)

804-379-1090

10710 MIDLOTHIAN TURNPIKE, NORTH CHESTERFIELD

Prossima data di guadagno

Ultimi documenti SEC

INDV's Discussions on Twitter

Compare INDV vs TAK, ZTS, HLN, TEVA, UTHR

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
INDV Indivior Pharmaceuticals Inc	30.47	3.71B	1.24B	209.00M	-94.86M	1.6605
TAK Takeda Pharmaceutical Co Adr	18.74	59.20B	29.85B	776.90M	4.35B	0.2408
ZTS Zoetis Inc	117.94	49.79B	9.47B	2.67B	2.28B	6.0218
HLN Haleon Plc Adr	9.93	44.27B	14.54B	2.22B	2.58B	0.4871
TEVA Teva Pharmaceutical Industries Ltd Adr	30.08	35.03B	17.41B	1.43B	1.00B	1.2182
UTHR United Therapeutics Corp	564.81	24.75B	3.18B	1.33B	1.04B	27.90

Indivior Pharmaceuticals Inc Stock (INDV) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-08-06	Iniziato	H.C. Wainwright	Buy
2025-07-22	Ripresa	Jefferies	Buy
2025-01-28	Iniziato	Rodman & Renshaw	Buy
2024-07-23	Iniziato	Piper Sandler	Overweight
2024-04-03	Iniziato	Craig Hallum	Buy
2023-07-13	Iniziato	Northland Capital	Outperform

Mostra tutto

Indivior Pharmaceuticals Inc Borsa (INDV) Ultime notizie

Indivior Pharmaceuticals Inc Azioni (INDV) Dati Finanziari

Indivior Pharmaceuticals Inc (INDV)

Indivior Pharmaceuticals Inc Stock (INDV) Company Profile

Compare INDV vs TAK, ZTS, HLN, TEVA, UTHR

Indivior Pharmaceuticals Inc Stock (INDV) Upgrades & Downgrades

Indivior Pharmaceuticals Inc Borsa (INDV) Ultime notizie

INDV Earning Date, Earning Analysis and Earning Prediction - intellectia.ai

INDV | Indivior Pharmaceuticals, Inc. Common Executive Compensation - Quiver Quantitative

INDV Financials: Revenue Breakdown, Margins & Competitor Comparison - intellectia.ai

Indivior Pharmaceuticals Inc. R (E7P.F) Insider Ownership & Holdings - Yahoo! Finance Canada

Indivior, Liquidia, Crinetics top Quant pharma list as Merck scoops up Terns for $6.7B - MSN

JPMorgan Chase & Co. Has $5.01 Million Holdings in Indivior PLC $INDV - MarketBeat

Did Potential Jail Staffing Efficiencies From SUBLOCADE® Just Shift Indivior Pharmaceuticals' (INDV) Investment Narrative? - Sahm

Indivior Pharmaceuticals, Inc. (INDV) stock price, news, quote and history - Yahoo Finance UK

Indivior Pharmaceuticals Inc. R (E7P.F) Valuation Measures & Financial Statistics - Yahoo! Finance Canada

Down 12.9% in 4 Weeks, Here's Why You Should You Buy the Dip in Indivior Pharmaceuticals Inc. (INDV) - MSN

Indivior Pharmaceuticals, Inc. (INDV) Stock forecasts - Yahoo Finance UK

INDV Technical Analysis & Stock Price Forecast - intellectia.ai

What Indivior Pharmaceuticals (INDV)'s Prison Cost Model Findings Mean For Shareholders - finance.yahoo.com

Indivior Pharmaceuticals, Inc. (INDV) Stock Forecasts - finance.yahoo.com

Indivior Pharmaceuticals, Inc. (INDV) Options Chain - Yahoo! Finance Canada

AGIO Rises on Mitapivat Progress Toward Accelerated Approval in SCD - The Globe and Mail

Indivior Pharmaceuticals, Inc - Reuters

Ultragenyx Pharmaceutical Announces FDA Acceptance of UX016 IND - TradingView

New Cost Impact Model Highlights Potential Benefits of Monthly Injectable Buprenorphine - National Today

New Cost Model Shows Monthly Injectable Buprenorphine Can Reduce Staffing Burdens in Prisons - National Today

New Cost Impact Model Highlights Potential for Monthly Injectable Buprenorphine to Reduce Staffing Burdens in Correctional Facilities - The Manila Times

Monthly opioid addiction shot may cut jail staffing, model estimates - Stock Titan

Zacks.com spotlights Indivior, Ciena, and Ultra Clean as notable mentions - Bitget

Zacks.com featured highlights include Indivior, Ciena and Ultra Clean - Yahoo Finance

FOCUS-Drugmakers delay some European launches with a wary eye on Trump's pricing policies - Sahm

Indivior PLC (NASDAQ:INDV) Short Interest Up 21.7% in March - MarketBeat

Indivior: Still Attractive After FY25 Earnings Beat (NASDAQ:INDV) - seekingalpha.com

Is It Time To Reassess Indivior Pharmaceuticals (INDV) After Its 200% One Year Surge? - simplywall.st

Hennion & Walsh Asset Management Inc. Purchases 96,177 Shares of Indivior PLC $INDV - MarketBeat

If You Invested $1,000 in Indivior Pharmaceuticals Inc. (INDV) - Stock Titan

SG Americas Securities LLC Buys 363,829 Shares of Indivior PLC $INDV - MarketBeat

Indivior PLC (NASDAQ:INDV) Given Average Recommendation of "Buy" by Analysts - MarketBeat

Levi & Korsinsky Reminds Indivior Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 1, 2024INDV - MarketScreener

Indivior (INDV) posts 2025 growth, SUBLOCADE gains and $400M buyback in 2026 proxy - Stock Titan

Suboxone Market Size Forecasts 2026-2033: Analyzing Industry - openPR.com

Indivior PLC Stock Faces Uncertainty Amid U.S. Domicile Shift and OUD Market Focus - ad-hoc-news.de

Indivior Pharmaceuticals Inc (INDV) Shares Up 5.07% on Mar 25 - GuruFocus

Indivior, Liquidia, Crinetics top Quant pharma list as Merck scoops up Terns for $6.7B (XLV:NYSEARCA) - Seeking Alpha

Down 12.9% Over the Past Month: Reasons to Consider Purchasing Indivior Pharmaceuticals Inc. (INDV) During the Decline - Bitget

FDA Grants Priority Tag to Ionis' NDA for Alexander Disease Drug - TradingView

[SCHEDULE 13G] Indivior Pharmaceuticals, Inc. Passive Investment Disclosure (>5%) - Stock Titan

Indivior Pharmaceuticals to report Q4 earnings: What's in the cards? - MSN

A Look At Indivior Pharmaceuticals (NasdaqGS:INDV) Valuation After Recent Share Price Weakness - Sahm

Implied volatility surging for Indivior Pharmaceuticals stock options - MSN

Indivior Pharmaceuticals Inc (INDV) Shares Gap Down to $29.44 on Mar 20 - GuruFocus

Indivior (NASDAQ:INDV) Upgraded by Zacks Research to "Strong-Buy" Rating - MarketBeat

Goldentree Asset Management LP Makes New Investment in Indivior PLC $INDV - MarketBeat

Indivior outlines 30% adjusted EBITDA growth target for 2026 with new $400M share repurchase program - MSN

Indivior Issues $500 Million Convertible Senior Notes Offering - TipRanks

[Form 4] Indivior Pharmaceuticals, Inc. Insider Trading Activity - Stock Titan

Indivior Pharmaceuticals Inc Azioni (INDV) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Simile a INDV